Delivery Order SPE2DB22D3004-SPE2DB24FPT32
Award Date 3/22/24
Potential Completion Date 3/25/24
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order contract valued at $21,820.59 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LIDOCAINE 5% PATCH 30S. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,619.48 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of LIDOCAINE 5% PATCH 30S. This order was placed under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a LIDOCAINE 5% PATCH 30S pharmaceutical product. The contract has a potential value of $1,863.98 and a completion date of January 29, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a maximum potential value of $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $4,492.30 for the supply of LIDOCAINE 5% PATCH 30S. This delivery order contract is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,744.98 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567523000 LIDOCAINE 5% PATCH 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563783939 units of LIDOCAINE 5% PATCH 30S. The contract has a potential value of $3,035.28 and a completion date of February 28, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4565334211 - LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $2,492.76 and is a Firm Fixed Price contract type. It is not set aside for any special designation. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, valued at up to $999,999,999 through...
- The U.S. Defense Logistics Agency (DLA) awarded a $37,505.17 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, Corporate Office Division, for the supply of 4565321162 LIDOCAINE 5% PATCH 30S. This order was placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4555305645 LIDOCAINE 5% PATCH 30S. The $2,410.00 contract has a performance period through November 4, 2021. Amerisourcebergen Drug Corp, as the prime contractor, is also the holder of a $999,999,999.00 indefinite delivery contract with DLA that serves as the primary vehicle for the company to...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,075.79 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of 4565733878 - LIDOCAINE 5% PATCH 30S, with a performance period ending on September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPT32Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,232.19 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4564054998 LIDOCAINE 5% PATCH 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Generated 6/21/24, 9:06 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 3/22/24 |